Carolinas Wealth Consulting’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
CB
Carolinas Wealth Consulting's IBB Position: Q2 2025 in Review
Carolinas Wealth Consulting sold out of iShares Biotechnology ETF (IBB) in Q2 2025, closing a stake of 3,562 shares — an estimated $456K sold.
Carolinas Wealth Consulting first reported a position in IBB in Q2 2020 and held it in 20 quarters. The position peaked at $2.18M in Q2 2020. 797 funds tracked by Wall St. Rank hold IBB as of Q2 2025.
- Carolinas Wealth Consulting reported no remaining iShares Biotechnology ETF position as of Q2 2025 after selling out during the quarter.
- Carolinas Wealth Consulting sold 3,562 iShares Biotechnology ETF shares in Q2 2025, an estimated $456K.
- Carolinas Wealth Consulting first reported a position in iShares Biotechnology ETF in Q2 2020 and held it in 20 quarters.
- Carolinas Wealth Consulting's iShares Biotechnology ETF position peaked at $2.18M in Q2 2020.
- 797 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2025.
Based on Carolinas Wealth Consulting's 13F filing for Q2 2025.